Gene-expression Profiling of CD34+ Hematopoietic Cells Expanded in a Collagen I Matrix
Overview
Reproductive Medicine
Authors
Affiliations
CD34+ hematopoietic stem/progenitor cells (HSCs) reside in the bone marrow in close proximity to the endosteal bone surface, surrounded by osteoblasts, stromal cells, and various extracellular matrix molecules. We used a bioartificial matrix of fibrillar collagen I, the major matrix component of bone, as a scaffold for ex vivo expansion of HSCs. CD34+ HSCs were isolated from umbilical cord blood and cultivated within reconstituted collagen I fibrils in the presence of fms-like tyrosine kinase-3 ligand, stem cell factor, and interleukin (IL)-3. After 7 days of culture, the cell number, number of colony-forming units (CFU-C), and gene-expression profile of the cultured cells were assessed. Although the total expansion factor of CD34+ cells was slightly lower when cells were cultivated in the collagen I gel, the frequency of CFU-C was greater than in control suspension cultures. Gene-expression analysis with microarray chip technology revealed the upregulation of more than 50 genes in the presence of collagen I. Among these, genes for several growth factors, cytokines, and chemokines (e.g., IL-8 and macrophage inhibitory protein 1alpha) could be confirmed using quantitative polymerase chain reaction. Furthermore, greater expression levels of the negative cell-cycle regulator BTG2/TIS21 and an inhibitor of the mitogen-activated protein kinase pathway, DUSP2, underline the regulatory role of the extracellular matrix. Together, these data show that the expansion of CD34+ cord blood cells in a culture system containing a three-dimensional collagen I matrix induces a qualitative change in the gene-expression profile of cultivated HSCs.
Hua J, Jiao T, Qiao Y, Zhang S, Xiao T, Zhang Y Ann Transl Med. 2023; 11(2):62.
PMID: 36819590 PMC: 9929769. DOI: 10.21037/atm-22-6383.
Jeong J, Jung I, Kim J, Jeon S, Hyeon D, Min H Cell Death Differ. 2022; 29(11):2151-2162.
PMID: 35473985 PMC: 9613645. DOI: 10.1038/s41418-022-01006-y.
Biomaterials as a Vital Frontier for Stem Cell-Based Tissue Regeneration.
Nugud A, Alghfeli L, Elmasry M, El-Serafi I, El-Serafi A Front Cell Dev Biol. 2022; 10:713934.
PMID: 35399531 PMC: 8987776. DOI: 10.3389/fcell.2022.713934.
Zmrhal V, Svoradova A, Batik A, Slama P Front Cell Dev Biol. 2022; 9:730804.
PMID: 35127695 PMC: 8811169. DOI: 10.3389/fcell.2021.730804.
Zhang P, Xu L, Gao J, Xu G, Song Y, Li G Bioact Mater. 2021; 10:255-268.
PMID: 34901544 PMC: 8636680. DOI: 10.1016/j.bioactmat.2021.08.032.